Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Ottawa

$238,045.00

Automated placenta screening to improve maternal lifetime cardiovascular health

FY 2019-20

Summary
The placenta is a critical organ of pregnancy, responsible for the exchange of all gases and nutrients between the mother and fetus. When the development or function of the placenta becomes compromised, common diseases of pregnancy can arise (e.g., hypertension in pregnancy, fetal growth restriction). It is now known that these diseases, which result from a damaged placenta, are significant risk factors for the development of cardiovascular disease (CVD) later in life. CVD is a leading cause of death for women. As such, several hospitals now run specialized follow up clinics for women following a pregnancy with placental disease, where their cardiovascular health is screened and prevention programs are offered. These clinics are a wonderful approach to tackle CVD in women, however, they are very expensive to run and are probably unnecessary for all women with placental disease, as ~50% of women referred to these clinics are later deemed to be at low risk for CVD. Our previous work has demonstrated that particular types of damage in the placenta, which can be seen under a microscope, are strongly associated with CVD risk at follow up. Unfortunately, visual screening by specialized pathologists is impractical as it is costly and unavailable in smaller hospitals and health care settings. The current research proposal will tackle this challenge, using machine learning methods to enable a computer to learn how to automatically detect these visual patterns in images of placentas from women who have high CVD risk. If successful, the developed technology will help streamline the identification and referral of high-priority women to cardiovascular screening and intervention programs in a cost- effective and timely fashion, ultimately improving the cardiovascular health of these women.
Program
Collaborative Health Research Projects (NSERC partnered)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
415681
Name
Bainbridge Shannon A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Automated placenta screening to improve maternal lifetime cardiovascular health
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$238,045
Cihrequipment2
$6,000
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Cardiovascular Disease; Computer Vision; Histopathology; Machine Learning; Placenta; Pregnancy; Screening Test; Women
Abstract
The placenta is a critical organ of pregnancy, responsible for the exchange of all gases and nutrients between the mother and fetus. When the development or function of the placenta becomes compromised, common diseases of pregnancy can arise (e.g., hypertension in pregnancy, fetal growth restriction). It is now known that these diseases, which result from a damaged placenta, are significant risk factors for the development of cardiovascular disease (CVD) later in life. CVD is a leading cause of death for women. As such, several hospitals now run specialized follow up clinics for women following a pregnancy with placental disease, where their cardiovascular health is screened and prevention programs are offered. These clinics are a wonderful approach to tackle CVD in women, however, they are very expensive to run and are probably unnecessary for all women with placental disease, as ~50% of women referred to these clinics are later deemed to be at low risk for CVD. Our previous work has demonstrated that particular types of damage in the placenta, which can be seen under a microscope, are strongly associated with CVD risk at follow up. Unfortunately, visual screening by specialized pathologists is impractical as it is costly and unavailable in smaller hospitals and health care settings. The current research proposal will tackle this challenge, using machine learning methods to enable a computer to learn how to automatically detect these visual patterns in images of placentas from women who have high CVD risk. If successful, the developed technology will help streamline the identification and referral of high-priority women to cardiovascular screening and intervention programs in a cost- effective and timely fashion, ultimately improving the cardiovascular health of these women.
Competitiondate
201910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bainbridge, Shannon A; Smith, Graeme N; Chan, Adrian D
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $238,045~ $6,000~
University of Ottawa - $238,045 Grant (2019-20) | Canada Spends